BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,308,286 | -3.1% | 608,515 | -3.6% | 0.00% | – |
| Q2 2023 | $4,445,866 | -11.1% | 631,515 | +5.3% | 0.00% | -100.0% |
| Q1 2023 | $5,003,000 | +54751.4% | 599,817 | -24.5% | 0.00% | 0.0% |
| Q4 2022 | $9,121 | -99.9% | 794,537 | +2.6% | 0.00% | 0.0% |
| Q3 2022 | $9,755,000 | +67.9% | 774,203 | +41.0% | 0.00% | 0.0% |
| Q2 2022 | $5,809,000 | +78.4% | 549,040 | +174.1% | 0.00% | – |
| Q1 2022 | $3,256,000 | +28.9% | 200,281 | +9.8% | 0.00% | – |
| Q4 2021 | $2,526,000 | -5.5% | 182,458 | -1.9% | 0.00% | – |
| Q3 2021 | $2,674,000 | -14.4% | 186,083 | -5.8% | 0.00% | – |
| Q2 2021 | $3,123,000 | +87.2% | 197,486 | +20.4% | 0.00% | – |
| Q1 2021 | $1,668,000 | +24.1% | 163,968 | -9.1% | 0.00% | – |
| Q4 2020 | $1,344,000 | +86.1% | 180,340 | -4.1% | 0.00% | – |
| Q3 2020 | $722,000 | -20.1% | 188,124 | -0.8% | 0.00% | – |
| Q2 2020 | $904,000 | +188.8% | 189,689 | +21.2% | 0.00% | – |
| Q1 2020 | $313,000 | -78.5% | 156,535 | -62.9% | 0.00% | – |
| Q4 2019 | $1,456,000 | -36.5% | 422,162 | -47.2% | 0.00% | – |
| Q3 2019 | $2,292,000 | +111.4% | 799,974 | +167.9% | 0.00% | – |
| Q2 2019 | $1,084,000 | -58.1% | 298,597 | -6.1% | 0.00% | -100.0% |
| Q1 2019 | $2,589,000 | -13.8% | 318,129 | -14.5% | 0.00% | 0.0% |
| Q4 2018 | $3,003,000 | +2.6% | 372,140 | -3.0% | 0.00% | 0.0% |
| Q3 2018 | $2,926,000 | +1717.4% | 383,561 | +1262.9% | 0.00% | – |
| Q2 2018 | $161,000 | +71.3% | 28,143 | +42.7% | 0.00% | – |
| Q1 2018 | $94,000 | -9.6% | 19,727 | -6.7% | 0.00% | – |
| Q4 2017 | $104,000 | -92.4% | 21,138 | -91.4% | 0.00% | – |
| Q2 2017 | $1,360,000 | -35.5% | 244,613 | -2.5% | 0.00% | – |
| Q1 2017 | $2,107,000 | +2378.8% | 250,855 | +1773.6% | 0.00% | – |
| Q4 2016 | $85,000 | -86.2% | 13,389 | -75.2% | 0.00% | – |
| Q3 2015 | $614,000 | -85.4% | 53,901 | -80.9% | 0.00% | -100.0% |
| Q2 2015 | $4,206,000 | +1078.2% | 281,700 | +671.4% | 0.00% | – |
| Q3 2014 | $357,000 | +9.5% | 36,520 | +42.5% | 0.00% | – |
| Q2 2014 | $326,000 | +132.9% | 25,622 | +93.0% | 0.00% | – |
| Q1 2014 | $140,000 | +129.5% | 13,278 | -66.5% | 0.00% | – |
| Q2 2013 | $61,000 | – | 39,595 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |